Resources Contact Us Home
20-HETE antagonists and agonists

Image Number 13 for United States Patent #6395781.

20-HETE agonists and antagonists are disclosed along with therapeutic applications. In a preferable form of the invention, the 20-HETE agonists are selected from the group consisting of 21-hydroxyheneicosa-5(Z),8(Z),11(Z),14(Z)-tetraenoic acid, 20-hydroxyeicosa-5(Z),14(Z)-dienoic acid and 20-,21-dimethyl 20-HETE. Preferable 20-HETE antagonists include 5(S)-HETE, 15(S)-HETE, 19(S)-HETE, 19-hydroxynonadeca-5(Z),8(Z),11(Z),14(Z)-tetraenoic acid and 20-hydroxyeicosa 6(Z),15(Z)-dienoic acid.

  Recently Added Patents
LED package chip classification system
Integrated circuit packaging system with an integral-interposer-structure and method of manufacture thereof
Scanning optical positioning system with spatially triangulating receivers
Catecholic butanes and use thereof for cancer therapy
Rules-based approach to transferring and/or viewing medical images
Method, apparatus or computer program for changing from scheduled to unscheduled communication modes
Communication system including a switching section for switching a network route, controlling method and storage medium
  Randomly Featured Patents
High-speed, precision, laser-based method and system for processing material of one or more targets within a field
Lightly doped drain MOS transistor
Adjustable spray tip
Vibrating screen deck support framework system
Preparation of prepregs from cellulosic fibers using water-borne resin compositions
Forward link signaling within a wireless power system
Method to identify voice over packet device capability and use it to make appropriate calls with other client devices
Image forming apparatus
Collapsible vane structure and related method for a shade for an architectural opening
Workflow management and control system